Viewing nowPregabalin 150 mg Capsule
Pregabalin 150mg
Hard capsule · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

MFDS item code 201604076 · Approved 2016.06.29 · Insurance code 663607070
Treatment of neuropathic pain and fibromyalgia, and adjunctive treatment of partial-onset seizures in epilepsy
This medication is used for the treatment of peripheral and central neuropathic pain in adults. It is also used as an adjunct for those experiencing partial seizures in epilepsy, effective regardless of the presence of generalized symptoms. Additionally, it helps alleviate the symptoms of fibromyalgia. This drug is extensively used for the treatment of peripheral and central neuropathic pain, partial seizures in epilepsy, and fibromyalgia.
Administer the total daily dose of pregabalin orally in 2 divided doses, regardless of food. Since this medicine is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function. (See section '5. Patients with renal impairment') 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: This medicine may be administered at an initial dose of 150 mg daily. Based on each patient's response and tolerability, the dose may be increased to 300 mg daily after 3 to 7 days. If necessary, it may subsequently be increased at 7-day intervals to a maximum of 600 mg daily. 2) Central neuropathic pain Adults: This medicine may be administered at an initial dose of 150 mg daily. Based on each patient's response and tolerability, the dose may be increased to 300 mg daily after 1 week. After an additional 1 week, it may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered. (See section '4. Discontinuation') 2. Epilepsy Adults: This medicine may be administered at an initial dose of 150 mg daily. Based on each patient's response and tolerability, the dose may be increased to 300 mg daily after 1 week. If necessary, it may subsequently be increased at 7-day intervals to a maximum of 600 mg daily. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg ~ 450 mg daily. The initial dose is 75 mg twice daily (150 mg daily) and, based on efficacy and tolerability, may be increased within 1 week to 150 mg twice daily (300 mg daily). For patients who do not experience sufficient benefit at a dose of 300 mg daily, the dose may be increased within 1 week to 225 mg twice daily (450 mg daily). Clinical studies have also been conducted at a dose of 600 mg daily, but there is no evidence of additional benefit or adequate tolerability at this dose. Considering dose-dependent adverse reactions, administration of doses exceeding 450 mg daily is not recommended. 4. Discontinuation Based on current clinical experience, if this medicine is discontinued, it should be tapered gradually over at least 1 week. 5. Patients with renal impairment After entering the systemic circulation, this medicine is excreted primarily by the kidneys unchanged. Since its clearance is directly affected by creatinine clearance, dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the formula below. *: For women, multiply the result obtained using the above formula by 0.85. This medicine is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, a supplemental dose should be administered immediately after each 4-hour hemodialysis session. [Table 1]. Pregabalin dosage based on renal function Creatinine clearance (CLcr), (mL/min) Total daily dose of pregabalin a Administration method Starting dose (mg/day) Maximum dose (mg/day) ≥60: 150, 600, BID or TID ≥30 -<60: 75, 300, BID or TID ≥15 -<30: 25-50, 150, QD or BID <15: 25, 75, QD Supplemental dose after hemodialysis: 25, 100, Single dose b TID = Divide the total daily dose into 3 doses BID = Divide the total daily dose into 2 doses QD = Administer once daily a: The total daily dose (mg/day) should be divided as specified under the administration method. b: The supplemental dose is a dose administered once in addition to the regular dose. 6. Patients with hepatic impairment No dose adjustment is required in patients with hepatic impairment. 8. Elderly patients (aged 65 years or older) Dose reduction may be necessary in elderly patients with impaired renal function.
7. Pediatric and adolescent patients Administration is not recommended in children under 12 years and adolescent patients aged 12 ~17 years because there are insufficient data on safety and efficacy.
This medication may increase the risk of suicidal thoughts or behaviors, so careful monitoring for abnormal changes in mood or behavior is necessary during treatment. Do not take if you have allergies to any component of this drug or certain genetic disorders such as lactose intolerance. Diabetic patients should be cautious as weight gain may require adjustment of blood sugar control medications. If symptoms of angioedema appear, immediately discontinue and consult a healthcare professional. Elderly patients should be cautious as this medication may cause dizziness or drowsiness, increasing the risk of falls. Transient blurred vision or changes in vision may occur, and if symptoms persist, consult a doctor. Abrupt discontinuation may lead to withdrawal symptoms such as insomnia, headache, and anxiety, so dosage should be gradually reduced according to a doctor's instructions. Patients with a history of substance abuse or mental disorders should be closely monitored for misuse or dependence risks with this medication. Patients with impaired renal function may require dosage adjustments and should be regularly monitored for changes in kidney function. Patients with heart disease should take this medication with caution due to the risk of cardiovascular problems such as congestive heart failure. Caution is needed if taking with other central nervous system depressants or opioid analgesics due to the risk of respiratory depression. In early pregnancy, this medication may pose a risk of congenital malformations to the fetus, therefore pregnant women should avoid taking it, and women of childbearing age should use effective contraception. If breastfeeding, this medication may be passed to the infant through breast milk, potentially affecting the infant, so it is recommended to either discontinue breastfeeding or the medication. Before engaging in potentially hazardous activities such as driving or operating machinery, ensure this medication does not cause dizziness or drowsiness. Severe skin reactions may occur, so if symptoms such as skin rash, swelling, or fever arise, immediately discontinue and consult a healthcare professional. In case of overdose, symptoms may include drowsiness, confusion, depression, seizures, and emergency treatment should be sought immediately, which may include blood dialysis if necessary. Keep this medication out of reach of children and do not transfer it to another container, as this may lead to degradation in quality or accidents.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect from air or moisture, and it is important to maintain a storage temperature between 15 degrees and 30 degrees Celsius. Proper storage will help maintain the medication's efficacy for a longer duration.
A capsule with a white upper and white lower part containing a powder that is white to light yellow.
30 capsules/bottle, 100 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 150mg
Hard capsule · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.